Lanxess (OTCMKTS:LNXSF) was downgraded by research analysts at UBS Group from a “buy” rating to a “neutral” rating in a research report issued on Thursday, www.briefing.com reports.
Separately, Macquarie downgraded shares of Lanxess from an “outperform” rating to a “neutral” rating in a research report on Thursday, November 29th.
OTCMKTS:LNXSF traded down $0.96 during trading hours on Thursday, hitting $55.70. 150 shares of the company were exchanged, compared to its average volume of 441. Lanxess has a 52-week low of $54.45 and a 52-week high of $90.95.
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.
Recommended Story: Futures Contract
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.